EpiTherapeutics: Built BRIC by BRIC
EpiTherapeutics leveraging Danish academic engine for new epigenetic targets
While EpiTherapeutics ApS is one of at least three companies founded since 2007 to work on histone methyltransferases or histone demethylases, the Danish biotech believes there are plenty of targets to go around.
It also thinks its access to a highly prolific academic research engine will set it apart from companies working on the same classes of epigenetic targets.
EpiTherapeutics was spun out of the University of Copenhagen's Biotech Research and Innovation Center